ADAG vs REGN: Which Stock is Better?

Side-by-side comparison of Adagene Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ADAG

Adagene Inc

$1.87

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricADAGREGNWinner
Market Cap$84.84M$77.77BREGN
P/E RatioN/A17.58REGN
EPS (TTM)$N/A$41.75REGN
Revenue Growth-0.9%0.0%REGN
Gross Margin100.0%45.8%ADAG

Analyze ADAG

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ADAG or REGN a better investment?

Comparing ADAG and REGN: Adagene Inc has a market cap of $84.84M while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ADAG and REGN?

ADAG (Adagene Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ADAG or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ADAG or REGN?

REGN has higher revenue growth at 0.0% vs -0.9% for ADAG.

Which company is more profitable: ADAG or REGN?

Adagene Inc (ADAG) has higher gross margins at 100.0% compared to 45.8% for REGN.

Which is the larger company: ADAG or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $84.84M for ADAG.

Should I buy ADAG or REGN in 2026?

Both ADAG and REGN have investment merit. ADAG trades at $1.87 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ADAG and REGN stock?

Key differences: Market Cap ($84.84M vs $77.77B), P/E Ratio (N/A vs 17.6x), Revenue Growth (-0.9% vs 0.0%), Gross Margin (100.0% vs 45.8%).

Popular Stock Comparisons